News

To combat rising maternal mortality, researchers at Saint Luke's Mid America Heart Institute and UMKC are leading a first of its kind study to create better care for moms with heart conditions during pregnancy.

Alexis Ellington has a renewed outlook on life after being the first Saint Luke's patient to receive a new cancer treatment called Bispecific T-cell Engagers therapy, or BiTE.

The four-year observational study will research U.S. pregnant people with cardiovascular disease to better understand and combat maternal mortality and morbidity.

In addition to her generous financial contributions, Denise has devoted her retirement to working on behalf of others with hearing loss.

We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.

In the past, many women born with a heart condition were told they would not be able to birth children safely.

Over the years, they have done everything together: graduated high school, tied the knot, bought their first home, and raised a family. For all they have shared, they never dreamed of sharing a cancer diagnosis.

Melody Unger loves to fill the world with sound. If the spirited 8-year-old isn’t singing, she’s humming, playing the drums, asking questions, or playing make-believe. But for the first two years of her life, Melody lived in silence.

Maddox was born with hereditary hearing loss. He received a cochlear implant. Watch how it changed his life.

Melody spent 136 days in the NICU. She didn't respond to sound. Read about her journey to be able to finally hear.